Cafepharma Today

January 28 2025 - Versant invests again in obesity, this time backing Helicore Biopharma
Versant invests again in obesity, this time backing Helicore Biopharma
Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer
Takeda regains home rights to phase 3-stage depression drug from Neurocrine
Stopwatch starts on reviews of GSK's long-acting asthma drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Allergan's Wrinkles Need Smoothing
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:32am
tags:
Isis Pharma Our Top Biotech
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:10am
tags:
MannKind shares gain ground on expectations for developing inhaled insulin product
Yahoo/AP
Wednesday, September 24, 2008 - 7:09am
tags:
Lone Bristol-Myers representative on ImClone board resigns as takeover effort turns hostile
Yahoo/AP
Wednesday, September 24, 2008 - 7:09am
tags:
Icahn calls new Bristol bid for ImClone "absurd"
Reuters
Wednesday, September 24, 2008 - 7:08am
tags:
A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.
Seeking Alpha
Wednesday, September 24, 2008 - 7:07am
tags:
Biotech Names With Big Potential
Seeking Alpha
Wednesday, September 24, 2008 - 7:06am
tags:
Schering-Plough Now Must Cut Costs
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:06am
tags:
Sanofi-Aventis gets FDA approval for pediatric use of allergy nasal spray
Yahoo/AP
Wednesday, September 24, 2008 - 7:05am
tags:
FDA Transparency Raises Volatility for Drug Company Shares
WSJ Online
Wednesday, September 24, 2008 - 7:05am
tags:
AstraZeneca Says Teva Denied Motion on Pulmicort
Bloomberg
Wednesday, September 24, 2008 - 7:04am
tags:
Daiichi Awaits India Approval for Ranbaxy After Tender Offer
Bloomberg
Wednesday, September 24, 2008 - 7:03am
tags:
Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
Yahoo
Tuesday, September 23, 2008 - 12:38pm
tags:
Genzyme Provides Details of October Myozyme (alglucosidase alfa) Advisory Panel Meeting and Additional Regulatory Updates
Yahoo
Tuesday, September 23, 2008 - 12:37pm
tags:
India's Ranbaxy hit by reports of Canada drug review
AFP
Tuesday, September 23, 2008 - 12:31pm
tags:
RegeneRx Enrolls First Subject In RGN-352 Phase IB Clinical Trial, Reducing Cardiac Damage In Patients After An AMI
Medical News Today
Tuesday, September 23, 2008 - 12:28pm
tags:
Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for Its Transdermal Lidocaine
PR NewsWire
Tuesday, September 23, 2008 - 12:27pm
tags:
Will Generic Biologics Get Special Treatment?
Motley Fool
Tuesday, September 23, 2008 - 12:26pm
tags:
GlaxoSmithKline Named a 2008 100 Best Company by Working Mother Magazine
Stockhouse, Canada
Tuesday, September 23, 2008 - 12:25pm
tags:
A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.
Seeking Alpha
Tuesday, September 23, 2008 - 12:23pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information